Asian Insight Provider - Actionable ideas, CrossASEAN Research

Henry Soediarko

A Long & Short Investment Ideas generator for Asian Equities with 10 years experience in a Hedge fund focused on bottom-up ideas, searching out mispriced ideas and misunderstood investment thesis. Provides on-the-ground insights in various Asian markets with a sway towards ASEAN. Experienced and survived the Asian Financial Crisis in a family business, as well as the Global Financial Crisis in financial markets where lessons learned. It's all about understanding business drivers and navigating business cycles, which has high applicability in generating investment ideas. 

Investment horizon: Mid to Long term

Asian Insight Provider - Actionable ideas

Travelsky (696): Beneficiary from Potential Reopening in China

Travelsky (696): The Ignored Travel Stock of China

Travelsky (696): Recovery and Undervalued Vs Airlines

Travelsky (696): Muted Impact from New Virus

Gravity Works As WeWork Doesn't; Now Plan B

CrossASEAN Research

At CrossASEAN Research we strive to produce unbiased and differentiated on the ground insights on companies across South East Asia. Our Research is produced for the most part after face to face meetings and conversations with company management to dig deep into the long term vision and strategy of the companies we cover. We seek to deliver investable and actionable themes on sectors and markets across SE Asia, often in collaboration with other Insight Providers across the region, pooling the vast experience of the analysts within the Smartkarma Ecosystem. We also offer bespoke work and tailor made trips for our clients. 

Insights across South East Asia

Equity Bottom-Up

Travelsky Technology Ltd H / Equity Bottom-Up

<ul>
<li>
<a href="https://www.smartkarma.com/entities/travelsky-technology-ltd-h" target="_blank" data-smartkarma-citation="entities:19829:1" rel="noopener">Travelsky Technology Ltd H (696 HK)</a> remains the proxy for Chinese domestic flights with a healthy balance sheet. </li>
<li>There has been no conclusion on the new variant, Omicron, on how infectious or how lethal it is compared to the previous variant. </li>
<li>Nevertheless, its earnings will suffer as the Chinese authorities will not take chances and increase scrutiny on flight safety to prevent further outbreaks.</li>
</ul>



Travelsky Technology Ltd H (696 HK) remains the proxy for Chinese domestic flights with a healthy balance sheet. 
There has been no conclusion on the new variant, Omicron, on how infectious or how lethal it is compared to the previous variant. 
Nevertheless, its earnings will suffer as the Chinese authorities will not take chances and increase scrutiny on flight safety to prevent further outbreaks.


Travelsky (696): Sell Despite Healthy Balance Sheet